Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PAM |
| Upstream (Parents) |
|---|
| (<<) PEBP1 → PAM |
| (<<) PRODH2 → PAM |
| (<<) MAFF → PAM |
| Downstream (Children) |
|---|
| PAM → ORAI2 (>>) |
| PAM → SFXN3 (>>) |
| PAM → ZNF134 (>>) |
| PAM → IL1A (>>) |
| PAM → F3 (>>) |
| PAM → MEP1B (>>) |
| PAM → NEU2 (>>) |
| PAM → CLTCL1 (>>) |
| PAM → RGS16 (>>) |
| PAM → FAM164A (>>) |
| PAM → LPCAT1 (>>) |
